An off-the-shelf multi-well scaffold-supported platform for tumour organoid-based tissues

NT Li, NC Wu, R Cao, JL Cadavid, S Latour, X Lu… - Biomaterials, 2022 - Elsevier
Complex 3D bioengineered tumour models provide the opportunity to better capture the
heterogeneity of patient tumours. Patient-derived organoids are emerging as a useful tool to …
被引用次数：11 相关文章
[PDF] archive.org

[PDF][PDF] An off-the-shelf multi-well scaffold-supported platform for tumour organoid-based tissues

NT Li, NC Wu, R Cao, JL Cadavid, S Latour, X Lu… - scholar.archive.org
Complex 3D bioengineered tumour models provide the opportunity to better capture the
heterogeneity of patient tumours. Patient-derived organoids are emerging as a useful tool to …

An off-the-shelf multi-well scaffold-supported platform for tumour organoid-based tissues

NT Li, NC Wu, R Cao, JL Cadavid, S Latour, X Lu… - bioRxiv, 2022 - biorxiv.org
Complex 3D bioengineered tumour models provide the opportunity to better capture the
heterogeneity of patient tumours. Patient-derived organoids are emerging as a useful tool to …

An off-the-shelf multi-well scaffold-supported platform for tumour organoid-based tissues

NT Li, NC Wu, R Cao, JL Cadavid, S Latour… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Complex 3D bioengineered tumour models provide the opportunity to better capture the
heterogeneity of patient tumours. Patient-derived organoids are emerging as a useful tool to …

An off-the-shelf multi-well scaffold-supported platform for tumour organoid-based tissues.

NT Li, NC Wu, R Cao, JL Cadavid, S Latour, X Lu… - Biomaterials, 2022 - europepmc.org
Complex 3D bioengineered tumour models provide the opportunity to better capture the
heterogeneity of patient tumours. Patient-derived organoids are emerging as a useful tool to …

An off-the-shelf multi-well scaffold-supported platform for tumour organoid-based tissues

NT Li, NC Wu, R Cao, JL Cadavid, S Latour, X Lu… - 2022 - europepmc.org
Complex 3D bioengineered tumour models provide the opportunity to better capture the
heterogeneity of patient tumours. Patient-derived organoids are emerging as a useful tool to …